Nivolumab-associated cutaneous T-cell lymphoma

by Jennifer A. Marks, MD, Douglas C. Parker, MD, L. Crain Garrot, MD, Mary Jo Lechowicz, MD
Published 2021-03-01

Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab

by Sarah A. Westergaard, MD, Mary Jo Lechowicz, MD, Maggie Harrington, NP-C, Justin Elsey, BS, Jack L. Arbiser, MD, PhD, Mohammad K. Khan, MD
Published 2020-08-01

Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma

by Auris Huen, Bradley M. Haverkos, Jasmine Zain, Ramchandren Radhakrishnan, Mary Jo Lechowicz, Sumana Devata, Neil J. Korman, Lauren Pinter-Brown, Yasuhiro Oki, Prajak J. Barde, Ajit Nair, Kasi Viswanath Routhu, Srikant Viswanadha, Swaroop Vakkalanka, Swaminathan P. Iyer
Published 2020-08-01